Qualigen Therapeutics

-$0.08 (-4.28%) Today
+$0.04 (+2.23%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell QLGN and other stocks, options, and ETFs commission-free!

About QLGN

Qualigen Therapeutics, Inc. Common Stock, also called Qualigen Therapeutics, is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases.

CEO
Michael S. Poirier
Employees
5
Headquarters
Los Angeles, California
Founded
2004

QLGN Key Statistics

Market Cap
54.11M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.21M
High Today
$1.90
Low Today
$1.76
Open Price
$1.87
Volume
344.21K
52 Week High
$19.75
52 Week Low
$1.71

QLGN Earnings

-$2.12
-$1.41
-$0.71
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
per share
Actual
Expected May 21, Pre-Market

You May Also Like

AESC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure